Apple hires secret employees to treat diabetes

Apple hires secret employees to treat diabetes

Apple Inc has already hired a team of professional biomedical engineers as part of its secret initiative, originally envisioned by late Apple co-founder Steve Jobs to design sensors to effectively treat diabetes. That’s what CNBC reported citing three folks already familiar with the matter.

However, an Apple representative refused to comment.

The newly hired engineers are supposed to work at a nondescript office, Palo Alto, California, which is close to the corporate headquarters, as CNBC informed.

The news arose at the time when the line between pharmaceuticals as well as technology is blurring because companies are struggling to cope with chronic diseases by means of high-tech devices, combining software, biology, hardware, thus jump-starting a novel field of medicine dubbed bioelectronics.

The previous year, GlaxoSmithKline Plc as well as Google parent Alphabet disclosed a joint company, specializing in marketing bioelectronic devices to withstand diseases by simply attaching to individual nerves.


Japan February export surge is caught speeding down

In February, Japan's exports tacked on at a slower tempo than in January because of the timing of the Lunar New Year holiday, although their upward trend’s supposed to stay unchanged with steady external demand, as a Reuters survey disclosed on Friday…


ECB Meeting

Traders are impatiently waiting for the European Central Bank’s meeting on October 26…


promotions you can be interested in

Deposit with your local payment systems


A manager will call you shortly.

Change number

Your request is accepted.

A manager will call you shortly.

Internal error. Please try again later

Beginner Forex book

The most important things to start trading
Enter your e-mail, and we will send you a free Beginner Forex book

Thank you!

We've emailed a special link to your e-mail.
Click the link to confirm your address and get Beginner Forex book for free.

You are using an older version of your browser.

Update it to the latest version or try another one for a safer, more comfortable and productive trading experience.

Safari Chrome Firefox Opera